TY - JOUR
T1 - Innovative method for rapid detection of falsified COVID-19 vaccines through unopened vials using handheld Spatially Offset Raman Spectroscopy (SORS)
AU - Mosca, Sara
AU - Lin, Qianqi
AU - Stokes, Robert
AU - Bharucha, Tehmina
AU - Gangadharan, Bevin
AU - Clarke, Rebecca
AU - Fernandez, Laura Gomez
AU - Deats, Michael
AU - Walsby-Tickle, John
AU - Arman, Benediktus Yohan
AU - Chunekar, Shrikrishna R.
AU - Patil, Kundan D.
AU - Gairola, Sunil
AU - Assche, Kerlijn Van
AU - Dunachie, Susanna
AU - Merchant, Hamid A.
AU - Kuwana, Rutendo
AU - Maes, Alexandrine
AU - McCullagh, James
AU - Caillet, Céline
AU - Zitzmann, Nicole
AU - Newton, Paul N.
AU - Matousek, Pavel
N1 - Funding Information:
We are grateful to WHO for funding this work (Ref. 2021/1170671-0). We also gratefully acknowledge two anonymous donor families and the Oak Foundation who provided funds to the University of Oxford to support this research. We also thank Agilent Technologies for the loan of the handheld instrument Resolve and the Serum Institute of India for the generous provision of vaccine samples. Furthermore, we would like to thank Sarah Gilbert, Adrian Hill, Andrew Pollard, Michelle Taylor-Simmonds, Islip Surgery, the Oxford University Hospitals NHS Foundation Trust and Cathrin Hauk of Oxford University for generous support of this project and expert advice. We also thank Sergei Kazarian of Imperial College, UK and Pierre-Yves Sacré of University of Liège, Belgium for their expert guidance. SJD acknowledges funding from NIHR Global Research Professorship (NIHR300791). MD, KVA, CC and PN are supported by the Wellcome Trust (222506/Z/21/Z). This work was funded in part by the Wellcome Trust (grant number 202935/Z/16/Z). For the purpose of Open Access, the author has applied a CC BY public copyright license to any Author Accepted Manuscript versions arising from this submission. The authors alone are responsible for the views expressed in this and they do not necessarily represent the views, decisions or policies of the institutions with which they are affiliated. The dataset supporting this paper is openly available both from Mendeley Data and eData at the STFC Research Data repository[24,25].
Funding Information:
Furthermore, we would like to thank Sarah Gilbert, Adrian Hill, Andrew Pollard, Michelle Taylor-Simmonds, Islip Surgery, the Oxford University Hospitals NHS Foundation Trust and Cathrin Hauk of Oxford University for generous support of this project and expert advice. We also thank Sergei Kazarian of Imperial College, UK and Pierre-Yves Sacré of University of Liège, Belgium for their expert guidance.
Funding Information:
We are grateful to WHO for funding this work (Ref. 2021/1170671-0). We also gratefully acknowledge two anonymous donor families and the Oak Foundation who provided funds to the University of Oxford to support this research. We also thank Agilent Technologies for the loan of the handheld instrument Resolve and the Serum Institute of India for the generous provision of vaccine samples.
Funding Information:
SJD acknowledges funding from NIHR Global Research Professorship (NIHR300791). MD, KVA, CC and PN are supported by the Wellcome Trust (222506/Z/21/Z).
Publisher Copyright:
© 2023 The Authors
PY - 2023/11/13
Y1 - 2023/11/13
N2 - Preventing, detecting, and responding to substandard and falsified vaccines is of critical importance for ensuring the safety, efficacy, and public trust in vaccines. This is of heightened importance in context of public health crisis, such as the COVID-19 pandemic, in which extreme world-wide shortages of vaccines provided a fertile ground for exploitation by falsifiers. Here, a proof-of-concept study explored the feasibility of using a handheld Spatially Offset Raman Spectroscopy (SORS) device to authenticate COVID-19 vaccines through rapid analysis of unopened vaccine vials. The results show that SORS can verify the chemical identity of dominant excipients non-invasively through vaccine vial walls. The ability of SORS to identify potentially falsified COVID-19 vaccines was demonstrated by measurement of surrogates for falsified vaccines contained in vaccine vials. In all cases studied, the SORS technique was able to differentiate between surrogate samples from the genuine COVISHIELD™ vaccine. The genuine vaccines tested included samples from six batches across two manufacturing sites to account for any potential variations between batches or manufacturing sites. Batch and manufacturing site variations were insignificant. In conjunction with existing security features, for example on labels and packaging, SORS provided an intrinsic molecular fingerprint of the dominant excipients of the vaccines. The technique could be extended to other COVID-19 and non-COVID-19 vaccines, as well as other liquid medicines. As handheld and portable SORS devices are commercially available and widely used for other purposes, such as airport security, they are rapidly deployable non-invasive screening tools for vaccine authentication.
AB - Preventing, detecting, and responding to substandard and falsified vaccines is of critical importance for ensuring the safety, efficacy, and public trust in vaccines. This is of heightened importance in context of public health crisis, such as the COVID-19 pandemic, in which extreme world-wide shortages of vaccines provided a fertile ground for exploitation by falsifiers. Here, a proof-of-concept study explored the feasibility of using a handheld Spatially Offset Raman Spectroscopy (SORS) device to authenticate COVID-19 vaccines through rapid analysis of unopened vaccine vials. The results show that SORS can verify the chemical identity of dominant excipients non-invasively through vaccine vial walls. The ability of SORS to identify potentially falsified COVID-19 vaccines was demonstrated by measurement of surrogates for falsified vaccines contained in vaccine vials. In all cases studied, the SORS technique was able to differentiate between surrogate samples from the genuine COVISHIELD™ vaccine. The genuine vaccines tested included samples from six batches across two manufacturing sites to account for any potential variations between batches or manufacturing sites. Batch and manufacturing site variations were insignificant. In conjunction with existing security features, for example on labels and packaging, SORS provided an intrinsic molecular fingerprint of the dominant excipients of the vaccines. The technique could be extended to other COVID-19 and non-COVID-19 vaccines, as well as other liquid medicines. As handheld and portable SORS devices are commercially available and widely used for other purposes, such as airport security, they are rapidly deployable non-invasive screening tools for vaccine authentication.
U2 - 10.1016/j.vaccine.2023.10.012
DO - 10.1016/j.vaccine.2023.10.012
M3 - Article
SN - 0264-410X
VL - 41
SP - 6960
EP - 6968
JO - Vaccine
JF - Vaccine
IS - 47
ER -